Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STROKECLOSE: LAAO vs Medical Therapy in AF Patients After ICH
NCT02830152Active, not recruiting
- Sponsor
- Karolinska Institutet
- Start
- May 2017
- Primary completion
- Dec 2027
- Countries
- 4
01
Overview
Randomised, open-label trial (2 arms), sponsored by Karolinska Institutet. Primary endpoint: Composite endpoint of stroke (ischemic and hemorrhagic), systemic embolism, life-threatening or major bleeding and all-cause mortality at 5 years. Started May 2017; status: active, not recruiting.
Beyond the preview
Go deeper on NCT02830152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02830152.